Plain-English translation of NCT02836262 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the HIT Hip Replacement System, a new artificial hip joint designed to replace a damaged hip in people with severe osteoarthritis. The device uses metal and plastic components that work together to restore movement and reduce pain. Researchers want to make sure this new system works safely and effectively in older adults who need hip replacement surgery.
While hip replacement surgery is a common and successful treatment, doctors are always looking for improved designs that might last longer, feel more natural, or work better for certain patients. This new system has been thoroughly tested in the laboratory, but this trial will be the first time it is used in actual patients to confirm it performs as expected.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo surgery to have your damaged hip replaced with the new HIT Hip Replacement System. Before surgery, you'll complete questionnaires about your pain and hip function. After surgery, you'll attend follow-up visits at the research site where doctors will monitor how well the new hip is working, check for any complications, and ask you to complete the same questionnaires to see how much your pain and movement have improved.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Canada
Sponsor
Hip Innovation Technology
Enrollment target
~100 participants
Started
August 2017
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
65 Years – 79 Years
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Linda Braddon, PhD
Orthopaedic Innovation Centre
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.